Related Experiment Videos

Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years

E Ben-Chetrit1, M Levy

  • 1Department of Medicine A, Hadassah University Hospital, Jerusalem, Israel.

Seminars in Arthritis and Rheumatism
|February 1, 1991
PubMed

Insights

Prolonged colchicine therapy is safe and effective for familial Mediterranean fever (FMF), preventing flares and amyloidosis. Discontinuation increases attack risk, while articular issues may need additional treatments.

Area of Science:

  • Rheumatology
  • Genetics
  • Internal Medicine

Background:

  • Familial Mediterranean fever (FMF) is a genetic autoinflammatory disorder.
  • FMF is characterized by recurrent inflammatory flares and risk of amyloidosis.
  • Colchicine is the established first-line treatment for FMF.

Purpose of the Study:

  • To evaluate the long-term safety and efficacy of colchicine in FMF patients.
  • To assess colchicine's role in preventing FMF flares and associated amyloidosis.
  • To determine colchicine's tolerability in specific populations like children and pregnant women.

Main Methods:

  • Prospective study of 45 patients with familial Mediterranean fever.
  • Analysis of treatment adherence, flare frequency, and adverse events.
  • Evaluation of outcomes including amyloidosis development and articular involvement.

Main Results:

  • Prolonged colchicine therapy demonstrated safety and efficacy in preventing FMF flares and amyloidosis.
  • An acceptable adverse effect profile was observed across the patient cohort.
  • Discontinuation of colchicine was linked to increased FMF attacks and amyloidosis.
  • Articular involvement showed limited response to colchicine, suggesting alternative therapies.

Conclusions:

  • Long-term colchicine therapy is a safe and effective strategy for managing FMF.
  • Colchicine is crucial for preventing FMF flares and systemic complications like amyloidosis.
  • While generally well-tolerated, specific conditions like articular involvement may necessitate adjunctive treatments.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...